Trial Profile
Efficacy of intravenous or oral vinorelbine in combination with cisplatin in patients with resected non-small cell lung cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jan 2016
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary) ; Vinorelbine (Primary) ; Cisplatin
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 28 Jan 2016 New trial record